Liposarcoma other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Liposarcoma}} | {{Liposarcoma}} | ||
{{CMG}} | |||
==Overview== | |||
===Genetic assessment=== | |||
The goals, risks and benefit of genetic assessment are numerous. A number of genetic conditions are associated with liposarcoma. Li-Fraumeni syndrome are the most common disease associated with it. The genes for TP53 mutations are tested in the tissue sample to detect Li-Fraumeni syndrome. | |||
==References== | ==References== | ||
| Line 9: | Line 13: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
Revision as of 04:07, 22 September 2014
|
Liposarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Liposarcoma other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Liposarcoma other diagnostic studies |
|
Risk calculators and risk factors for Liposarcoma other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Genetic assessment
The goals, risks and benefit of genetic assessment are numerous. A number of genetic conditions are associated with liposarcoma. Li-Fraumeni syndrome are the most common disease associated with it. The genes for TP53 mutations are tested in the tissue sample to detect Li-Fraumeni syndrome.
References